Downregulation of Steroid Receptor Coactivator-2 Modulates Estrogen-Responsive Genes and Stimulates Proliferation of MCF-7 Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Fenne, Ingvild S ^a,b   Helland, Thomas ^a,b   Flågeng, Marianne H ^a,b   Dankel, Simon N ^a,b   Mellgren, Gunnar ^a,b   Sagen, Jørn V ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CAVEOLIN 1; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP DEPENDENT PROTEIN KINASE; EARLY GROWTH RESPONSE FACTOR 1; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN RET; SHORT HAIRPIN RNA; TRANSGELIN;

ADM GENE; AKR1B10 GENE; ARTICLE; BCAS1 GENE; BCL11B GENE; BREAST CANCER; CANCER GROWTH; CAV1 GENE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CXCR4 GENE; DOWN REGULATION; EGR1 GENE; ENZYME ACTIVATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; RET GENE; TAGLN GENE; TFF3 GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MCF-7 CELLS; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENES; PROTEOLYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 84880784754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070096     Document Type: Article

References (70)

1. Onate SA, Tsai SY, Tsai MJ, O'Malley BW, (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357.
2. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR, (1996) GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci U S A 93: 4948-4952.
3. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H, (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. Embo J 15: 3667-3675.
4. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, et al. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
5. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, et al. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580.
6. Li H, Gomes PJ, Chen JD, (1997) RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci U S A 94: 8479-8484.
7. Takeshita A, Cardona GR, Koibuchi N, Suen CS, Chin WW, (1997) TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem 272: 27629-27634.
8. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, et al. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684.
9. Gehin M, Mark M, Dennefeld C, Dierich A, Gronemeyer H, et al. (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22: 5923-5937.
10. Mukherjee A, Amato P, Craig-Allred D, DeMayo FJ, O'Malley BW, et al. (2007) Steroid receptor coactivator 2: an essential coregulator of progestin-induced uterine and mammary morphogenesis. Ernst Schering Found Symp Proc: 55-76.
11. Jeong JW, Kwak I, Lee KY, White LD, Wang XP, et al. (2006) The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. Mol Endocrinol 20: 1138-1152.
12. Picard F, Gehin M, Annicotte J, Rocchi S, Champy MF, et al. (2002) SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111: 931-941.
13. Modder UI, Monroe DG, Fraser DG, Spelsberg TC, Rosen CJ, et al. (2009) Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2. J Biol Chem 284: 18767-18777.
14. Reineke EL, York B, Stashi E, Chen X, Tsimelzon A, et al. (2012) SRC-2 Coactivator Deficiency Decreases Functional Reserve in Response to Pressure Overload of Mouse Heart. PLoS One 7: e53395.
15. Jeong JW, Lee KY, Han SJ, Aronow BJ, Lydon JP, et al. (2007) The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and-dependent gene expression. Endocrinology 148: 4238-4250.
16. Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BW, (2003) Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23: 3763-3773.
17. Won Jeong K, Chodankar R, Purcell DJ, Bittencourt D, Stallcup MR, (2012) Gene-specific patterns of coregulator requirements by estrogen receptor-alpha in breast cancer cells. Mol Endocrinol 26: 955-966.
18. Li S, Shang Y, (2007) Regulation of SRC family coactivators by post-translational modifications. Cell Signal 19: 1101-1112.
19. Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR, (2002) Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci U S A 99: 16701-16706.
20. Cvoro A, Tzagarakis-Foster C, Tatomer D, Paruthiyil S, Fox MS, et al. (2006) Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 21: 555-564.
21. Rogatsky I, Zarember KA, Yamamoto KR, (2001) Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 20: 6071-6083.
22. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, et al. (2013) Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49: 158-171.
23. Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, et al. (2004) Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol 57: 1069-1074.
24. Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, et al. (2000) Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res 60: 6266-6271.
25. Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, et al. (2004) Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. Br J Cancer 91: 1687-1693.
26. Qin L, Liao L, Redmond A, Young L, Yuan Y, et al. (2008) The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28: 5937-5950.
27. Qin L, Liu Z, Chen H, Xu J, (2009) The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 69: 3819-3827.
28. Zhao C, Yasui K, Lee CJ, Kurioka H, Hosokawa Y, et al. (2003) Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer 98: 18-23.
29. Karmakar S, Foster EA, Smith CL, (2009) Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity. Endocrinology 150: 1588-1596.
30. Planas-Silva MD, Shang Y, Donaher JL, Brown M, Weinberg RA, (2001) AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 61: 3858-3862.
31. List HJ, Lauritsen KJ, Reiter R, Powers C, Wellstein A, et al. (2001) Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem 276: 23763-23768.
32. Xu J, Wu RC, O'Malley BW, (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615-630.
33. Zhang H, Yi X, Sun X, Yin N, Shi B, et al. (2004) Differential gene regulation by the SRC family of coactivators. Genes Dev 18: 1753-1765.
34. Zwart W, Theodorou V, Kok M, Canisius S, Linn S, et al. (2011) Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J 30: 4764-4776.
35. Fenne IS, Hoang T, Hauglid M, Sagen JV, Lien EA, et al. (2008) Recruitment of coactivator glucocorticoid receptor interacting protein 1 to an estrogen receptor transcription complex is regulated by the 3′,5′-cyclic adenosine 5'-monophosphate-dependent protein kinase. Endocrinology 149: 4336-4345.
36. Hoang T, Fenne IS, Cook C, Borud B, Bakke M, et al. (2004) cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. J Biol Chem 279: 49120-49130.
37. Hoang T, Fenne IS, Madsen A, Bozickovic O, Johannessen M, et al. (2013) cAMP Response Element-Binding Protein Interacts With and Stimulates the Proteasomal Degradation of the Nuclear Receptor Coactivator GRIP1. Endocrinology 154: 1513-1527.
38. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
39. Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD, et al. (2001) Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A 98: 10781-10786.
40. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
41. Borud B, Hoang T, Bakke M, Jacob AL, Lund J, et al. (2002) The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol Endocrinol 16: 757-773.
42. Assinder SJ, Stanton JA, Prasad PD, (2009) Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 41: 482-486.
43. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D, (2006) The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 13: 115-124.
44. Kamimura K, Mishima Y, Obata M, Endo T, Aoyagi Y, et al. (2007) Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages. Oncogene 26: 5840-5850.
45. Hino M, Doihara H, Kobayashi K, Aoe M, Shimizu N, (2003) Caveolin-1 as tumor suppressor gene in breast cancer. Surg Today 33: 486-490.
46. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, et al. (1998) Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A 95: 8703-8708.
47. Eng C, (1999) RET proto-oncogene in the development of human cancer. J Clin Oncol 17: 380-393.
48. Morandi A, Plaza-Menacho I, Isacke CM, (2011) RET in breast cancer: functional and therapeutic implications. Trends Mol Med 17: 149-157.
49. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, et al. (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-971.
50. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, et al. (2002) The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 94: 1226-1237.
51. Walsh CA, Qin L, Tien JC, Young LS, Xu J, (2012) The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci 8: 470-485.
52. Ma G, Ren Y, Wang K, He J, (2011) SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int J Biol Sci 7: 664-672.
53. O'Donnell KA, Keng VW, York B, Reineke EL, Seo D, et al. (2012) A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 109: E1377-1386.
54. Jennings CJ, O'Grady A, Cummins R, Murer B, Al-Alawi M, et al. (2012) Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma. J Thorac Oncol 7: 243-248.
55. Grivas PD, Tzelepi V, Sotiropoulou-Bonikou G, Kefalopoulou Z, Papavassiliou AG, et al. (2009) Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int J Colorectal Dis 24: 613-622.
56. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, et al. (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61: 4315-4319.
57. Kershah SM, Desouki MM, Koterba KL, Rowan BG, (2004) Expression of estrogen receptor coregulators in normal and malignant human endometrium. Gynecol Oncol 92: 304-313.
58. Kefalopoulou Z, Tzelepi V, Zolota V, Grivas PD, Christopoulos C, et al. (2012) Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol 106: 23-31.
59. Haugan Moi LL, Hauglid Flageng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, et al. (2010) Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue. Clin Cancer Res 16: 2176-2186.
60. Flageng MH, Moi LL, Dixon JM, Geisler J, Lien EA, et al. (2009) Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer 101: 1253-1260.
61. Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, et al. (2006) ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate 66: 1474-1486.
62. Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, et al. (2006) Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol 20: 45-55.
63. Mucignat-Caretta ACaC (2011) Protein Kinase A in Cancer. Cancers. 913-926.
64. Al-Dhaheri MH, Rowan BG (2006) PKA exhibits selective modulation of estradiol dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered ER{alpha} promoter interaction and changes in receptor phosphorylation. Mol Endocrinol.
65. Dudek P, Picard D, (2008) Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells. PLoS One 3: e1859.
66. Kung W, Roos W, Eppenberger U, (1983) Growth stimulation of human breast cancer MCF-7 cells by dibutyryl cyclic AMP. Cell Biol Int Rep 7: 345-351.
67. Lamb D, Steinberg RA, (2002) Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. J Cell Physiol 192: 216-224.
68. Xu J, Li Q, (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17: 1681-1692.
69. Tien JC, Zhou S, Xu J, (2009) The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression. Int J Biol Sci 5: 256-264.
70. York B, Sagen JV, Tsimelzon A, Louet JF, Chopra AR, et al. (2013) Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Mol Endocrinol 27: 366-380.